StockWatch
·
Biotechnology: Pharmaceutical Preparations
InvestmentJul 30, 2026, 02:25 PM

60 Degrees Pharma Raises $1.0M in Private Placement

AI Summary

60 Degrees Pharmaceuticals, Inc. announced it has entered into definitive agreements for a private placement to issue and sell an aggregate of 574,713 shares of its common stock (or pre-funded warrants) along with Series A and short-term Series B warrants. The purchase price is $1.74 per share and accompanying warrants, with an exercise price of $1.49 per share for the warrants. The offering is expected to generate approximately $1.0 million in gross proceeds, which the company intends to use for working capital and general corporate purposes.

Key Highlights

  • Entered definitive agreements for a private placement of common stock and warrants.
  • Issuance of 574,713 shares of common stock (or pre-funded warrants).
  • Issuance of Series A warrants to purchase up to 574,713 shares.
  • Issuance of short-term Series B warrants to purchase up to 574,713 shares.
  • Purchase price of $1.74 per share (or pre-funded warrant) and accompanying warrants.
  • Warrants have an exercise price of $1.49 per share.
  • Expected gross proceeds of approximately $1.0 million.
  • Net proceeds to be used for working capital and general corporate purposes.